000154169 001__ 154169
000154169 005__ 20240229123057.0
000154169 0247_ $$2doi$$a10.1158/1055-9965.EPI-19-1409
000154169 0247_ $$2pmid$$apmid:32188599
000154169 0247_ $$2ISSN$$a1055-9965
000154169 0247_ $$2ISSN$$a1538-7755
000154169 0247_ $$2altmetric$$aaltmetric:78589402
000154169 037__ $$aDKFZ-2020-00628
000154169 041__ $$aeng
000154169 082__ $$a610
000154169 1001_ $$0P:(DE-He78)bc9ae72f1f27696587eeb1c81e48fb69$$aNeumeyer, Sonja Maria$$b0$$eFirst author$$udkfz
000154169 245__ $$aGenetic predictors of circulating 25-hydroxyvitamin D and prognosis after colorectal cancer.
000154169 260__ $$aPhiladelphia, Pa.$$bAACR$$c2020
000154169 3367_ $$2DRIVER$$aarticle
000154169 3367_ $$2DataCite$$aOutput Types/Journal article
000154169 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1601023737_15373
000154169 3367_ $$2BibTeX$$aARTICLE
000154169 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000154169 3367_ $$00$$2EndNote$$aJournal Article
000154169 500__ $$a2020 Jun;29(6):1128-1134#EA:C020#LA:C020#
000154169 520__ $$aLow serum 25-hydroxyvitamin D (25(OH)D) concentrations in colorectal cancer (CRC) patients have been consistently associated with higher mortality in observational studies. It is unclear whether low 25(OH)D levels directly influence CRC mortality. To minimize bias, we use genetic variants associated with vitamin D levels to evaluate the association with overall and CRC-specific survival.Six genetic variants have been robustly identified to be associated with 25(OH)D levels in genome-wide association studies. Based on data from the International Survival Analysis in Colorectal Cancer Consortium (ISACC) the individual genetic variants and a weighted genetic risk score were tested for association with overall and CRC-specific survival using Cox proportional hazards models in 7 657 stage I-IV CRC patients of which 2 438 died from any cause and 1 648 died from CRC.The 25(OH)D decreasing allele of single nucleotide polymorphism (SNP) rs2282679 (GC) was associated with poorer CRC-specific survival, although not significant after multiple-testing correction. None of the other five SNPs showed an association. The genetic risk score showed non-significant associations with increased overall (HR=1.54, 95% CI:0.86-2.78) and CRC-specific mortality (HR=1.76, 95% CI:0.86-3.58). A significant increased risk of overall mortality was observed in women (HR=3.26, 95% CI:1.45-7.33, p-value for heterogeneity=0.01) and normal-weight individuals (HR=4.14, 95% CI:1.50-11.43, p-value for heterogeneity=0.02).Our results provided little evidence for an association of genetic predisposition of lower vitamin D levels with increased overall or CRC-specific survival, although power might have been an issue.Further studies are warranted to investigate the association in specific subgroups.
000154169 536__ $$0G:(DE-HGF)POF3-313$$a313 - Cancer risk factors and prevention (POF3-313)$$cPOF3-313$$fPOF III$$x0
000154169 588__ $$aDataset connected to CrossRef, PubMed,
000154169 7001_ $$0P:(DE-He78)7ca7eafba864e5c3ebb7598149380452$$aButterbach, Katja$$b1
000154169 7001_ $$00000-0001-7332-7117$$aBanbury, Barbara L$$b2
000154169 7001_ $$aBerndt, Sonja I$$b3
000154169 7001_ $$aCampbell, Peter T$$b4
000154169 7001_ $$aChlebowski, Rowan T$$b5
000154169 7001_ $$aChan, Andrew T$$b6
000154169 7001_ $$aGiovannucci, Edward L$$b7
000154169 7001_ $$aJoshi, Amit D$$b8
000154169 7001_ $$aOgino, Shuji$$b9
000154169 7001_ $$aSong, Mingyang$$b10
000154169 7001_ $$aMcCullough, Marjorie L$$b11
000154169 7001_ $$aMaalmi, Haifa$$b12
000154169 7001_ $$aManson, JoAnn E$$b13
000154169 7001_ $$00000-0002-0900-5735$$aSakoda, Lori C$$b14
000154169 7001_ $$00000-0001-7153-2766$$aSchoen, Robert E$$b15
000154169 7001_ $$00000-0002-1655-6543$$aSlattery, Martha L$$b16
000154169 7001_ $$aWhite, Emily$$b17
000154169 7001_ $$00000-0002-2794-5261$$aWin, Aung K$$b18
000154169 7001_ $$aFigueiredo, Jane C$$b19
000154169 7001_ $$aHopper, John L$$b20
000154169 7001_ $$aMacrae, Finlay A$$b21
000154169 7001_ $$aPeters, Ulrike$$b22
000154169 7001_ $$0P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2$$aBrenner, Hermann$$b23$$udkfz
000154169 7001_ $$0P:(DE-He78)6c5d058b7552d071a7fa4c5e943fff0f$$aHoffmeister, Michael$$b24$$udkfz
000154169 7001_ $$aNewcomb, Polly A$$b25
000154169 7001_ $$0P:(DE-He78)c259d6cc99edf5c7bc7ce22c7f87c253$$aChang-Claude, Jenny$$b26$$eLast author$$udkfz
000154169 773__ $$0PERI:(DE-600)2036781-8$$a10.1158/1055-9965.EPI-19-1409$$gp. cebp.1409.2019 -$$n6$$p1128-1134$$tCancer epidemiology, biomarkers & prevention$$v29$$x1538-7755$$y2020
000154169 909CO $$ooai:inrepo02.dkfz.de:154169$$pVDB
000154169 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)bc9ae72f1f27696587eeb1c81e48fb69$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000154169 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)7ca7eafba864e5c3ebb7598149380452$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000154169 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2$$aDeutsches Krebsforschungszentrum$$b23$$kDKFZ
000154169 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)6c5d058b7552d071a7fa4c5e943fff0f$$aDeutsches Krebsforschungszentrum$$b24$$kDKFZ
000154169 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)c259d6cc99edf5c7bc7ce22c7f87c253$$aDeutsches Krebsforschungszentrum$$b26$$kDKFZ
000154169 9131_ $$0G:(DE-HGF)POF3-313$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vCancer risk factors and prevention$$x0
000154169 9141_ $$y2020
000154169 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bCANCER EPIDEM BIOMAR : 2017
000154169 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000154169 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000154169 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000154169 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List
000154169 915__ $$0StatID:(DE-HGF)0110$$2StatID$$aWoS$$bScience Citation Index
000154169 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000154169 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000154169 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine
000154169 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences
000154169 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews
000154169 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5
000154169 9202_ $$0I:(DE-He78)C020-20160331$$kC020$$lC020 Epidemiologie von Krebs$$x0
000154169 9200_ $$0I:(DE-He78)C020-20160331$$kC020$$lC020 Epidemiologie von Krebs$$x0
000154169 9201_ $$0I:(DE-He78)C020-20160331$$kC020$$lC020 Epidemiologie von Krebs$$x0
000154169 9201_ $$0I:(DE-He78)C070-20160331$$kC070$$lC070 Klinische Epidemiologie und Alternf.$$x1
000154169 9201_ $$0I:(DE-He78)C120-20160331$$kC120$$lPräventive Onkologie$$x2
000154169 9201_ $$0I:(DE-He78)HD01-20160331$$kHD01$$lDKTK HD zentral$$x3
000154169 980__ $$ajournal
000154169 980__ $$aVDB
000154169 980__ $$aI:(DE-He78)C020-20160331
000154169 980__ $$aI:(DE-He78)C070-20160331
000154169 980__ $$aI:(DE-He78)C120-20160331
000154169 980__ $$aI:(DE-He78)HD01-20160331
000154169 980__ $$aUNRESTRICTED